MORGAN STANLEY - MEDTECH ACQUISITION CORP ownership

MEDTECH ACQUISITION CORP's ticker is MTAC and the CUSIP is 58507N105. A total of 11 filers reported holding MEDTECH ACQUISITION CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of MEDTECH ACQUISITION CORP
ValueSharesWeighting
Q4 2022$40,622
+1.6%
4,0500.0%0.00%
Q3 2022$40,0000.0%4,0500.0%0.00%
Q2 2022$40,0000.0%4,0500.0%0.00%
Q1 2022$40,0000.0%4,0500.0%0.00%
Q4 2021$40,000
-4.8%
4,050
-3.7%
0.00%
Q3 2021$42,000
+4100.0%
4,204
+4104.0%
0.00%
Q2 2021$1,000
-50.0%
100
-55.6%
0.00%
Q1 2021$2,0002250.00%
Other shareholders
MEDTECH ACQUISITION CORP shareholders Q1 2023
NameSharesValueWeighting ↓
MYDA Advisors LLC 403,070$3,910,0000.98%
Park West Asset Management LLC 1,250,000$12,125,0000.34%
SPRING CREEK CAPITAL LLC 503,600$4,885,0000.24%
ARISTEIA CAPITAL, L.L.C. 1,153,485$11,189,0000.22%
CVI Holdings, LLC 250,000$2,425,0000.16%
Context Capital Management, LLC 174,065$1,688,0000.16%
K.J. Harrison & Partners Inc 140,000$1,359,0000.14%
Radcliffe Capital Management, L.P. 414,584$4,021,0000.13%
Omni Partners US LLC 220,971$2,143,0000.09%
Vestcor Inc 276,074$2,694,0000.09%
View complete list of MEDTECH ACQUISITION CORP shareholders